Ubiquitin is part of the retrovirus budding machinery.

Retroviruses contain relatively large amounts of ubiquitin, but the significance of this finding has been unknown. Here, we show that drugs that are known to reduce the level of free ubiquitin in the cell dramatically reduced the release of Rous sarcoma virus, an avian retrovirus. This effect was suppressed by overexpressing ubiquitin and also by directly fusing ubiquitin to the C terminus of Gag, the viral protein that directs budding and particle release. The block to budding was found to be at the plasma membrane, and electron microscopy revealed that the reduced level of ubiquitin results in a failure of mature virus particles to separate from each other and from the plasma membrane during budding. These data indicate that ubiquitin is actually part of the budding machinery.

[1]  J. Yewdell,et al.  Proteasome inhibition interferes with gag polyprotein processing, release, and maturation of HIV-1 and HIV-2. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[2]  G. Palù,et al.  A role for ubiquitin ligase recruitment in retrovirus release. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[3]  J. Wills,et al.  Membrane Targeting Properties of a Herpesvirus Tegument Protein-Retrovirus Gag Chimera , 2000, Journal of Virology.

[4]  S. Yamasaki,et al.  A Di-leucine Signal in the Ubiquitin Moiety , 2000, The Journal of Biological Chemistry.

[5]  A. Ciechanover,et al.  Ubiquitin‐mediated proteolysis: biological regulation via destruction , 2000, BioEssays : news and reviews in molecular, cellular and developmental biology.

[6]  L. Schild,et al.  Regulation of the epithelial Na+ channel by Nedd4 and ubiquitination. , 2000, Kidney international.

[7]  L. Hicke,et al.  Monoubiquitin carries a novel internalization signal that is appended to activated receptors , 2000, The EMBO journal.

[8]  S. Goff,et al.  Mutations altering the Moloney murine leukemia virus p12 Gag protein affect virion production and early events of the virus life cycle , 1999, The EMBO journal.

[9]  C. Crews,et al.  Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[10]  V. Vogt,et al.  Mass Determination of Rous Sarcoma Virus Virions by Scanning Transmission Electron Microscopy , 1999, Journal of Virology.

[11]  R. N. Harty,et al.  A Proline-Rich Motif within the Matrix Protein of Vesicular Stomatitis Virus and Rabies Virus Interacts with WW Domains of Cellular Proteins: Implications for Viral Budding , 1999, Journal of Virology.

[12]  R. N. Harty,et al.  Late Domain Function Identified in the Vesicular Stomatitis Virus M Protein by Use of Rhabdovirus-Retrovirus Chimeras , 1999, Journal of Virology.

[13]  J. Wills,et al.  Identification of Retroviral Late Domains as Determinants of Particle Size , 1999, Journal of Virology.

[14]  J. Wills,et al.  Conditions for Copackaging Rous Sarcoma Virus and Murine Leukemia Virus Gag Proteins during Retroviral Budding , 1999, Journal of Virology.

[15]  S. Emr,et al.  Fab1p PtdIns(3)P 5-Kinase Function Essential for Protein Sorting in the Multivesicular Body , 1998, Cell.

[16]  Simon C Watkins,et al.  Equine Infectious Anemia Virus Gag Polyprotein Late Domain Specifically Recruits Cellular AP-2 Adapter Protein Complexes during Virion Assembly , 1998, Journal of Virology.

[17]  K. Simons,et al.  The differential miscibility of lipids as the basis for the formation of functional membrane rafts. , 1998, Biochimica et biophysica acta.

[18]  L. Ratner,et al.  Particle Size Determinants in the Human Immunodeficiency Virus Type 1 Gag Protein , 1998, Journal of Virology.

[19]  E. Hunter,et al.  A Proline-Rich Motif (PPPY) in the Gag Polyprotein of Mason-Pfizer Monkey Virus Plays a Maturation-Independent Role in Virion Release , 1998, Journal of Virology.

[20]  P. Spearman,et al.  The I Domain Is Required for Efficient Plasma Membrane Binding of Human Immunodeficiency Virus Type 1 Pr55Gag , 1998, Journal of Virology.

[21]  H. Yeger,et al.  The C2 Domain of the Ubiquitin Protein Ligase Nedd4 Mediates Ca2+-dependent Plasma Membrane Localization* , 1997, The Journal of Biological Chemistry.

[22]  L. Hicke Ubiquitin‐dependent internalization and down‐regulation of plasma membrane proteins , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[23]  W. Baumeister,et al.  Active Site-directed Inhibitors of Rhodococcus 20 S Proteasome , 1997, The Journal of Biological Chemistry.

[24]  J. Wills,et al.  Equine infectious anemia virus utilizes a YXXL motif within the late assembly domain of the Gag p9 protein , 1997, Journal of virology.

[25]  G. Vaduva,et al.  MDP1, a Saccharomyces cerevisiae gene involved in mitochondrial/cytoplasmic protein distribution, is identical to the ubiquitin-protein ligase gene RSP5. , 1997, Genetics.

[26]  A. Goldberg,et al.  Selective Inhibitors of the Proteasome-dependent and Vacuolar Pathways of Protein Degradation in Saccharomyces cerevisiae * , 1996, The Journal of Biological Chemistry.

[27]  C. Cameron,et al.  Fine mapping and characterization of the Rous sarcoma virus Pr76gag late assembly domain , 1996, Journal of virology.

[28]  M. Sudol,et al.  WW domains and retrovirus budding , 1996, Nature.

[29]  C. Larsen,et al.  Metabolism of the polyubiquitin degradation signal: structure, mechanism, and role of isopeptidase T. , 1995, Biochemistry.

[30]  E. Freed,et al.  p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease , 1995, Journal of virology.

[31]  B. Baird,et al.  Fc epsilon RI-mediated recruitment of p53/56lyn to detergent-resistant membrane domains accompanies cellular signaling. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[32]  J. Wills,et al.  Positionally independent and exchangeable late budding functions of the Rous sarcoma virus and human immunodeficiency virus Gag proteins , 1995, Journal of virology.

[33]  C. Cameron,et al.  An assembly domain of the Rous sarcoma virus Gag protein required late in budding , 1994, Journal of virology.

[34]  A. Kaplan,et al.  The activity of the protease of human immunodeficiency virus type 1 is initiated at the membrane of infected cells before the release of viral proteins and is required for release to occur with maximum efficiency , 1994, Journal of virology.

[35]  C. Pickart,et al.  Substrate properties of site-specific mutant ubiquitin protein (G76A) reveal unexpected mechanistic features of ubiquitin-activating enzyme (E1). , 1994, The Journal of biological chemistry.

[36]  J. Wills,et al.  Necessity of the spacer peptide between CA and NC in the Rous sarcoma virus gag protein , 1993, Journal of virology.

[37]  M. Ellison,et al.  Expression of a ubiquitin derivative that conjugates to protein irreversibly produces phenotypes consistent with a ubiquitin deficiency. , 1992, The Journal of biological chemistry.

[38]  J. Wills,et al.  Suppression of retroviral MA deletions by the amino-terminal membrane-binding domain of p60src , 1991, Journal of virology.

[39]  J. Sodroski,et al.  Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[40]  M. G. Oliver,et al.  Incorporation of chimeric gag protein into retroviral particles , 1990, Journal of virology.

[41]  V. Vogt,et al.  Ubiquitin in avian leukosis virus particles. , 1990, Virology.

[42]  M. Lai,et al.  Continuous tissue culture cell lines derived from chemically induced tumors of Japanese quail , 1977, Cell.

[43]  D. Brown,et al.  Functions of lipid rafts in biological membranes. , 1998, Annual review of cell and developmental biology.

[44]  L. Hicke,et al.  A function for monoubiquitination in the internalization of a G protein-coupled receptor. , 1998, Molecular cell.